Issue 36, 2011

Ribosomal synthesis of backbone macrocyclic peptides

Abstract

A wealth of knowledge has been accumulated on ribosomal synthesis of macrocyclic peptides in the past decade. In nature, backbone cyclization of the translated linear peptides is generally catalyzed by specific enzymes, giving them peptidase resistance, thermodynamic stability and various other physiological activities. Due to these biochemical traits, backbone cyclic peptides have become an attractive resource for the discovery of drug leads. Recently, various new methodologies have also been established to generate man-made cyclic peptides. Here, we describe the biosynthetic mechanisms of naturally occurring backbone macrocyclic peptides focusing on cyclotides, sunflower trypsin inhibitors (SFTIs) and cyanobactins as well as several new emerging methodologies, such as sortase mediated ligation, protein splicing method and genetic code reprogramming.

Graphical abstract: Ribosomal synthesis of backbone macrocyclic peptides

Article information

Article type
Highlight
Submitted
05 May 2011
Accepted
24 Jun 2011
First published
15 Jul 2011

Chem. Commun., 2011,47, 9946-9958

Ribosomal synthesis of backbone macrocyclic peptides

T. Katoh, Y. Goto, Md. S. Reza and H. Suga, Chem. Commun., 2011, 47, 9946 DOI: 10.1039/C1CC12647D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements